New drug combo shows promise against lung cancer before surgery
NCT ID NCT07141563
First seen Jan 08, 2026 · Last updated May 15, 2026 · Updated 19 times
Summary
This study looked back at medical records of 70 adults in Argentina with a certain type of lung cancer (non-small cell lung cancer) that could be removed with surgery. All patients received a combination of the immunotherapy drug nivolumab and chemotherapy before their surgery. The goal was to see how well this treatment worked in real-world settings, specifically how many patients had no cancer cells left in their removed tissue. The study is complete and provides information on the effectiveness and safety of this approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Grupo Argentino Oncología Torácica (GAOT) - Asociación Argentina Oncología Clínica (AAOC)
Buenos Aires, C1426CPU, Argentina
Conditions
Explore the condition pages connected to this study.